Quarterly report pursuant to Section 13 or 15(d)

Supplemental Disclosure of Cash Flow Information (Tables)

v3.19.3.a.u2
Supplemental Disclosure of Cash Flow Information (Tables)
9 Months Ended
Sep. 30, 2019
Supplemental Cash Flow Elements [Abstract]  
Schedule of Supplemental Cash Flow Information

    Nine Months Ended September 30,  
    2019     2018  
Cash paid for interest   $ -     $ 303,208  
Cash paid for income taxes     45,000       20,000  
                 
Acquisitions of Hospitals and Medical Center:                
Cash   $ -     $ 375  
Inventory     317,427       450,682  
Prepaid expenses and other current assets     -       310,385  
Property and equipment     500,000       7,129,484  
Intangible assets     250,000       504,806  
Accrued expenses     158,890       193,966  
                 
Non-cash investing and financing activities:                
Exchange of Series I-2 Preferred Stock for common stock   $ 1,143,974     $ 633,101  
Cashless exercise of warrants     11,961       4,619,150  
Debentures converted into common stock     -       8,085,342  
Common stock issued in cashless exercise of warrants     11,961       -  
Exchange of debentures into Series I-2 Preferred Stock     -       1,420  
Conversions of Series H Preferred Stock into common stock     -       50,000  
Original issue discount of debentures and notes payable     400,000       1,920,000  
Deemed dividend for trigger of down round provision features     123,861,587       17,942,578  
Issuance of Series J Preferred Stock in settlement of note payable to related party     -       250,000